Antoni Ribas, MD, PhD
The members of the American Association for Cancer Research (AACR) recently elected Antoni Ribas, MD, PhD, as its President-Elect for 2019–2020. He officially became President-Elect at the 2019 AACR Annual Meeting and will assume the presidency at the 2020 AACR Annual Meeting in San Diego.
The voting members of the AACR also elected five members to serve on the AACR Board of Directors for the 2019–2022 term. These new directors began their terms at the 2019 AACR Annual Meeting.
Dr. Ribas is Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA); Director of the UCLA Jonsson Comprehensive Cancer Center Tumor Immunology Program; and Director of the Parker Institute for Cancer Immunotherapy Center at UCLA.
The following five cancer researchers have been elected to the AACR Board of Directors for 2019–2022:
- Marcia Cruz-Correa, MD, PhD, Professor of Medicine and Biochemistry, University of Puerto Rico Medical Sciences Campus; Chair, Division of Cancer Biology, University of Puerto Rico Comprehensive Cancer Center, San Juan.
- Keith Flaherty, MD, Director of Clinical Research, Massachusetts General Hospital Cancer Center, Boston.
- Karen E. Knudsen, PhD, Enterprise Director and Member, Executive Committee, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia.
- Martine Roussel, PhD, Member, Department of Tumor Cell Biology, Endowed Chair in Molecular Oncogenesis, and Co-Leader, Comprehensive Cancer Center Cancer Biology Program, St. Jude Children’s Research Hospital, Memphis.
- Charles Swanton, MD, PhD, Royal Society Napier Professor of Cancer Medicine and Chair of Personalised Cancer Medicine, University College London. ■
